When a mother uses opioids during pregnancy, doctors know it can affect her baby's health. But what's happening inside the baby's body? A new, small pilot study tried to get a clearer picture by looking at a specific growth-related signal in newborns. The researchers compared babies exposed to opioids in the womb with those who weren't. They checked the babies' saliva for levels of a protein called adiponectin receptor 1, which is involved in how the body uses energy and grows. They also took detailed measurements of the babies' body fat and lean mass. It's important to understand this is just a first, exploratory step. The study was observational, meaning it can only show a possible connection, not prove that opioid exposure causes changes. The researchers haven't reported their specific findings yet, so we don't know what they actually found. This work is about building a foundation for future research to understand the biological pathways that might be involved.
How does a mother's opioid use affect her baby's growth signals?
Photo by Google DeepMind / Unsplash
What this means for you:
Early study explores a biological link between maternal opioid use and infant growth signals. More on Opioid Use Disorder
Study protocol for screening nulliparous women to prevent preeclampsia and fetal growth restriction A new plan to screen for pregnancy risks is being tested in a UK hospital.
medRxiv · Apr 30, 2026
Meta-analysis finds Eat-Sleep-Console care reduces neonatal opioid withdrawal hospital stay Less Medicine Helps Babies Recover From Withdrawal Faster
Frontiers · Apr 29, 2026
Combination buprenorphine and psychotherapy linked to highest remission rates in opioid dependence patients Combining buprenorphine and therapy boosts remission rates for opioid dependence
Frontiers · Apr 28, 2026
Network meta-analysis of LMWH and aspirin for high-risk singleton pregnancies with fetal growth restriction New Treatment Cuts Risk of Dangerous Pregnancy Complication
Frontiers · Apr 19, 2026